Thermo Fisher Scientific Inc (TMO) Shares Sold by SeaBridge Investment Advisors LLC

SeaBridge Investment Advisors LLC lowered its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 2.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,884 shares of the medical research company’s stock after selling 420 shares during the period. SeaBridge Investment Advisors LLC’s holdings in Thermo Fisher Scientific were worth $3,573,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Rockefeller Financial Services Inc. raised its holdings in shares of Thermo Fisher Scientific by 85.5% in the third quarter. Rockefeller Financial Services Inc. now owns 18,389 shares of the medical research company’s stock worth $3,479,000 after buying an additional 8,477 shares during the last quarter. Arcadia Investment Management Corp MI increased its stake in shares of Thermo Fisher Scientific by 8.2% in the third quarter. Arcadia Investment Management Corp MI now owns 45,960 shares of the medical research company’s stock worth $8,696,000 after acquiring an additional 3,497 shares during the period. Arrow Financial Corp increased its stake in shares of Thermo Fisher Scientific by 81.5% in the third quarter. Arrow Financial Corp now owns 4,225 shares of the medical research company’s stock worth $800,000 after acquiring an additional 1,897 shares during the period. Assenagon Asset Management S.A. acquired a new stake in shares of Thermo Fisher Scientific in the third quarter worth $7,614,000. Finally, Diamond Hill Capital Management Inc. increased its stake in shares of Thermo Fisher Scientific by 50.5% in the third quarter. Diamond Hill Capital Management Inc. now owns 1,075,604 shares of the medical research company’s stock worth $203,504,000 after acquiring an additional 360,911 shares during the period. 83.78% of the stock is owned by institutional investors and hedge funds.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) opened at $189.08 on Wednesday. The company has a market cap of $75,471.34, a price-to-earnings ratio of 20.68, a P/E/G ratio of 1.72 and a beta of 1.08. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85. Thermo Fisher Scientific Inc has a 52-week low of $139.07 and a 52-week high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.24 by $0.07. The company had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The firm’s revenue was up 13.9% on a year-over-year basis. During the same quarter last year, the business earned $2.03 earnings per share. equities analysts expect that Thermo Fisher Scientific Inc will post 9.36 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Friday, December 15th will be given a $0.15 dividend. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $0.60 annualized dividend and a dividend yield of 0.32%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.19%.

A number of research firms have recently weighed in on TMO. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $215.00 price objective on the stock in a research note on Tuesday, October 31st. Leerink Swann reiterated a “buy” rating on shares of Thermo Fisher Scientific in a research note on Monday, October 30th. Deutsche Bank AG set a $226.00 price objective on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Thursday, October 26th. Jefferies Group LLC reiterated a “hold” rating and issued a $195.00 price objective on shares of Thermo Fisher Scientific in a research note on Thursday, September 28th. Finally, Goldman Sachs Group, Inc. (The) began coverage on shares of Thermo Fisher Scientific in a research note on Tuesday, September 26th. They issued a “buy” rating and a $225.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $205.71.

ILLEGAL ACTIVITY NOTICE: “Thermo Fisher Scientific Inc (TMO) Shares Sold by SeaBridge Investment Advisors LLC” was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this report on another website, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The correct version of this report can be accessed at https://sportsperspectives.com/2017/11/15/thermo-fisher-scientific-inc-tmo-shares-sold-by-seabridge-investment-advisors-llc.html.

In other news, Director C Martin Harris sold 360 shares of Thermo Fisher Scientific stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total value of $65,149.20. Following the sale, the director now owns 5,312 shares in the company, valued at $961,312.64. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Jim P. Manzi sold 11,318 shares of Thermo Fisher Scientific stock in a transaction dated Friday, August 18th. The shares were sold at an average price of $172.94, for a total transaction of $1,957,334.92. Following the completion of the sale, the director now owns 38,757 shares in the company, valued at approximately $6,702,635.58. The disclosure for this sale can be found here. In the last quarter, insiders sold 22,738 shares of company stock worth $4,021,512. Company insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply